menu search

Silk Road Medical Stock (SILK) Nosedives on CEO Departure and Revenue Shortfall

Silk Road Medical Stock (SILK) Nosedives on CEO Departure and Revenue Shortfall
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages SILK Investors with Substantial Losses to Contact Firm’s Attorneys SAN FRANCISCO, Oct. 11, 2023 (GLOBE NEWSWIRE) — Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now. Hagens Berman is investigating potential violations of the securities laws. Visit: www.hbsslaw.com/investor-fraud/SILK Contact […] The post Silk Road Medical Stock (SILK) Nosedives on CEO Departure an... Read More
Posted: Oct 11 2023, 22:16
Author Name: forextv
Views: 082625

Search within

Pages Search Results: